Sign Up to like & get
recommendations!
0
Published in 2024 at "Molecular Pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.3c00700
Abstract: 4-Chlorokynurenine (4-Cl-KYN, AV-101) is a prodrug of a NMDA receptor antagonist and is in clinical development for potential CNS indications. We sought to further understand the distribution and metabolism of 4-Cl-KYN, as this information might…
read more here.
Keywords:
acetyl kyn;
distribution;
chlorokynurenine;
drug ... See more keywords